MAPT and Alzheimer disease: Given the crucial role of miRNAs in the expression of genes that are key to AD pathology, their relative stability, tissue enrichment, and amenability to quantitative measurement [15], we speculated that measuring single or multiple miRNAs may reflect the concentration of Aβ and tau in the brains of AD patients.